Search Results 1011-1020 of 17182 for treatment resistant depression

  1. https://www.mayoclinic.org/patient_consumer_faq.xml

    ... depression/expert-answers/clinical-depression/faq-20057770</loc><lastmod>2024-09-30T18:38:37-05:00</lastmod><xhtml:link rel="alternate" hreflang="es" href ...

  2. Publications - Cynthia O. Townsend, Ph.D., L.P. - Mayo Clinic

    Cognitive behavioral therapy, self-efficacy, and depression in persons with chronic pain. ... Treatment outcomes after multidisciplinary pain rehabilitation with ...

  3. Housecall: Dealing with arthritis pain - Mayo Clinic News Network

    ... medication and stress reduction, but how do you know what will ... If you think you may be depressed, seek medical help as soon as possible. Depression ...

  4. Treating pain responsibly in the midst of an opioid epidemic - Mayo Clinic

    We need to be vigilant for side effects, such as respiratory depression, sedation, nausea, constipation and pruritus. At the same time, we need to consider ...

  5. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the safety and tolerability of ONO-7475 monotherapy in patients with relapsed or refractory acute myeloid leukemia or ...

  6. Publications - David Toro Tobon, M.D. - Mayo Clinic

    Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers. Thyroid. 2024 Jan; 34(1):70-81 ...

  7. A Study to Evaluate Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer - Mayo Clinic

    Duloxetine increases the amount of certain chemicals in the brain that help relieve depression and pain. Giving duloxetine in patients undergoing treatment with ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the safety and tolerability of ONO-7475 monotherapy in patients with relapsed or refractory acute myeloid leukemia or ...

  9. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I- ...

  10. Epilepsy - Doctors and departments - Mayo Clinic

    Diagnosis & treatmentCare at Mayo Clinic. Oct. 14, 2023. Print. Living ... drug-resistant epilepsy April 07, 2025, 02:16 p.m. CDT; (VIDEO) When seizures ...